Unlocking Genomic Potential: A Comprehensive Overview of the NGS Automation Market Landscape

1. By Product: In 2022, the workstation/robotic platform segment is anticipated to hold the largest market share. This segment's growth is attributed to the rising demand for automation within NGS workflows. Pharmaceutical and biotechnology companies, as well as diagnostic laboratories, are increasingly adopting robotic platforms and workstations to enhance efficiency and productivity. Moreover, government funding for drug discovery and research is facilitating the expansion of this segment.

2. By Application: The drug discovery segment is projected to account for the largest share in 2022. This growth can be linked to the increasing utilization of NGS in identifying novel drug targets and developing targeted therapeutic techniques, including gene therapies and oligonucleotide therapies. As the demand for automation in drug discovery continues to rise, this segment will likely experience robust growth.

3. By Sequencing Type: In 2022, the whole genome sequencing (WGS) segment is estimated to hold the largest market share. WGS provides significant advantages in discovery applications, such as identifying causative variants and novel genome assemblies. The ability of WGS to detect single nucleotide variants, insertions/deletions, and structural variants enhances its appeal, particularly in cancer diagnosis and targeted therapy within precision oncology.

4. By End User: The pharmaceutical and biotechnology companies segment is expected to capture the largest share in 2022. This growth is driven by increased R&D expenditures and the growing demand for novel drug discoveries using advanced technologies. The financial capabilities of these companies enable them to invest in NGS automation workstations and acquire skilled personnel, further driving the segment's growth.

• North America (U.S., Canada)
• Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe)
• Asia-Pacific (Japan, China, India, and the Rest of Asia-Pacific)
• Latin America
• Middle East & Africa

• Agilent Technologies, Inc. (U.S.)
• Danaher Corporation (U.S.)
• Eppendorf AG (Germany)
• Hamilton Company (U.S.)
• PerkinElmer, Inc. (U.S.)
• Tecan Group Ltd. (Switzerland)
• PRIMADAG SAS (France)
• BRAND GMBH + CO KG (Germany)
• Hudson Robotics (U.S.)
• SPT Labtech (U.K.)
• Thermo Fisher Scientific Inc. (U.S.)
• F. Hoffmann-La Roche AG (Switzerland)